Skip to main content

Search
News

Kineta, Children’s join in pediatric clinical-trial effort

|

Kineta, Children’s join in pediatric clinical-trial effort

June 12, 2014

http://seattletimes.com/html/businesstechnology/2023824050_kinetachildrensxml.html

 

Source - Seattle Times


Seattle biotechnology company Kineta and Seattle Children’s Research Institute are joining in an effort to improve development and testing of therapies for pediatric autoimmune diseases. Their collaboration, called Alliance for Children’s Therapeutics, will be funded both by philanthropic gifts to the research institute and equity investments in Kineta. Its initial aim is to raise $1.5 million and conduct clinical trials of a Kineta drug in treating childhood-onset lupus nephritis, a spokesman said. Researchers say clinical trials of new drugs typically don’t include children, creating uncertainty about the effects and dosages.

Press Contacts for Media Interviews

Email for Media Interviews
press@seattlechildrens.org
Phone for Media Interviews
206-987-4500
Monday through Friday
8:30 a.m. to 5:30 p.m. Pacific time (non-holidays)
Urgent After Hours for Media Interviews
206-987-2000
Call switchboard to page Media Relations staff on call

Latest News

The Fault in “The Fault in Our Stars”
7.24.14 — On the Pulse Blog

I loved “The Fault in Our Stars.” Both the book and the movie. I read the book a few years ago during a flight. I cried so hard ... cont.

Doctor uses scorpion venom to locate cancer cells
7.23.14 — FOX News

Dr. James Olson is a pediatric oncologist at Seattle Children’s, and the scientist who developed a compound using a protein ... cont.

Boy healing quickly after heart transplant
7.22.14 — The Columbian

In less than two weeks, Jack Conover went from being a 7-year-old in need of a heart transplant to a vibrant boy walking out of ... cont.